Microbot Medical Inc. Raises $4.2 Million Through Exercise of Series G Options, Issuing Over 2.3 Million Common Shares
Microbot Medical Inc. has issued a total of 2,395,715 shares of its common stock at a par value of $0.01 per share. These shares were issued upon the exercise of outstanding Series G preferred investment options by their holders at an exercise price of $1.75 per share. The transaction generated gross proceeds of approximately $4.2 million before deducting placement agent fees and expenses. These shares were issued under the exemption provided by Section 4(a)(2) of the Securities Act of 1933 and were registered for resale on a Registration Statement on Form S-3.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-021486), on July 30, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。